Maria Soloveychik
Chief Executive Officer & Co-Founder SyntheX
• 18+ years in molecular biology and biochemistry, with a focus on drug discovery and genetic engineering
• Contributed to 9 published PDB structures, discovered novel epigenetic signaling pathways
• Spearheaded venture fundraising, business development, company building & scaling from ideation stage
Seminars
Thursday 30th October 2025
Transforming Molecular Glue Discovery with ToRNeDO: An Empirical, Cell-Based Discovery Platform
3:00 pm
- Presenting ToRNeDO, SyntheX’s molecular glue selection platform that bypasses serendipitous screening
- Enabling functional selection of target/ligase pairs and mapping of novel degrons for rational glue design
- Discovering a molecular glue against a novel effector with exquisite target selectivity to drive new therapeutic strategies
